Indeed, p53 deficiency in association with activating mutations of oncogenes, such as RAS and BRAF, accounts for the high proliferation rate and increased aggressiveness of the more aggressive forms of thyroid cancer (95). The gene discussed is BRAF; the disease is thyroid gland carcinoma.